Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

144.05
Delayed Data
As of Oct 20
 -0.95 / -0.66%
Today’s Change
95.80
Today|||52-Week Range
163.75
+32.12%
Year-to-Date
Analysts Take Action on Health Care Stocks
Oct 20 / GuruFocus News - Paid Partner Content
5 Health Care Companies in Gurus' Portfolios
Oct 16 / GuruFocus News - Paid Partner Content
ImmunoGen to Push Leukemia Candidate into Phase I Trial
Oct 17 / Zacks.com - Paid Partner Content
5 Health Care Companies in Gurus' Portfolios
Oct 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close145.00
Today’s open145.00
Day’s range143.30 - 145.97
Volume299,602
Average volume (3 months)440,209
Market cap$8.7B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+22.56%
Earnings growth (this year)+7.36%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+12.32%
P/E ratio22.2
Price/Sales4.53
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.93-0.80%
ALKSAlkermes Plc+0.02+0.04%
SGENSeattle Genetics Inc-0.15-0.23%
TSROTESARO Inc+0.89+0.77%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$2.89
Annual revenue (last year)$1.5B
Annual profit (last year)$396.8M
Net profit margin26.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts